Effect of alirocumab on specific lipoprotein non-high-density lipoprotein cholesterol and subfractions as measured by the vertical auto profile method: analysis of 3 randomized trials versus placebo
about
Physiological and therapeutic regulation of PCSK9 activity in cardiovascular disease.Design and rationale of the ODYSSEY DM-DYSLIPIDEMIA trial: lipid-lowering efficacy and safety of alirocumab in individuals with type 2 diabetes and mixed dyslipidaemia at high cardiovascular risk.PCSK9 targets important for lipid metabolismHigh-density Lipoprotein and Low-density Lipoprotein Therapeutic Approaches in Acute Coronary Syndromes.Pharmacological management of diabetic dyslipidemia.Target-Mediated Drug Disposition Population Pharmacokinetics Model of Alirocumab in Healthy Volunteers and Patients: Pooled Analysis of Randomized Phase I/II/III Studies.Investigational therapies for hypercholesterolemia.Threshold Effects of Circulating Angiopoietin-Like 3 Levels on Plasma Lipoproteins.Effects of PCSK9 Inhibitors on Other than Low-Density Lipoprotein Cholesterol Lipid Variables.
P2860
Q33599961-4AEE9A0A-8ED6-4963-830B-824167261F8AQ33730396-AB9ABBBB-35AC-47C0-AE97-BB25E915D77BQ37703261-64A791D0-21D8-4005-99F4-48AD6812B2D8Q38965138-114625F0-4DFD-4558-A4B2-5B9CD3901A0DQ39015072-BB32293D-335B-4EFF-A521-6FC6D4858F4EQ39034676-53C03D72-3131-4E09-B4EF-F200CAEC111DQ39215123-8C3FA318-FF0A-4C05-B6B2-898C79E20667Q46347201-CB4B13B0-3AC4-45F2-8CD0-70E913497078Q48209248-12D84EDC-8703-4097-A1BB-D8AEB0A07227
P2860
Effect of alirocumab on specific lipoprotein non-high-density lipoprotein cholesterol and subfractions as measured by the vertical auto profile method: analysis of 3 randomized trials versus placebo
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Effect of alirocumab on specif ...... ndomized trials versus placebo
@ast
Effect of alirocumab on specif ...... ndomized trials versus placebo
@en
type
label
Effect of alirocumab on specif ...... ndomized trials versus placebo
@ast
Effect of alirocumab on specif ...... ndomized trials versus placebo
@en
prefLabel
Effect of alirocumab on specif ...... ndomized trials versus placebo
@ast
Effect of alirocumab on specif ...... ndomized trials versus placebo
@en
P2093
P2860
P1476
Effect of alirocumab on specif ...... ndomized trials versus placebo
@en
P2093
Corinne Hanotin
Eli M Roth
James M McKenney
Krishnaji R Kulkarni
Parag H Joshi
Peter P Toth
Poulabi Banerjee
Sara C Hamon
Seth S Martin
Steven R Jones
P2860
P2888
P356
10.1186/S12944-016-0197-4
P577
2016-02-13T00:00:00Z
P5875
P6179
1011257117